NeurAxis Stock (NASDAQ:NRXS)

Revenue Ownership Financials Chart Transcripts

Previous Close

$3.10

52W Range

$2.00 - $3.89

50D Avg

$2.92

200D Avg

$3.06

Market Cap

$22.69M

Avg Vol (3M)

$11.96K

Beta

-

Div Yield

-

NRXS Company Profile

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19

IPO Date

Aug 09, 2023

Website

NRXS Performance

NRXS Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$2.46M	$2.68M	$2.72M
Operating Income	$-6.66M	$-3.37M	$-2.97M
Net Income	$-14.63M	$-4.78M	$-3.07M
EBITDA	$-6.62M	$-5.65M	$-2.93M
Basic EPS	-	$-0.78	$-0.57
Diluted EPS	-	$-0.78	$-0.57

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 12, 24 | 9:00 AM

Q2 24Aug 11, 24 | 5:44 AM

Q1 24May 22, 24 | 1:34 PM